ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TYRA vs ANAB // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Tyra Biosciences Inc. (NASDAQ) VS. AnaptysBio Inc. (NASDAQ) • 15-METRIC TALLY: TYRA 2 — ANAB 3
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TYRA VS. ANAB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TYRA ANAB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 85.00% -120.00 ANAB /roic <GO>
EV/EBITDA & P/E Valuation — 5.7x — TIE /valuation <GO>
Free Cash Flow Yield -6.45% 1.36% -7.81 ANAB /fcf-yield <GO>
Operating Margin — 75.00% — TIE /operating-margins <GO>
Net Profit Margin — -5.60% — TIE /net-margins <GO>
Revenue Growth (YoY) — 157.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 ANAB /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.8 48.0 +3.80 TYRA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.48B $1.44B $36.7M TYRA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TYRA REV ANAB REV TYRA GROSS % ANAB GROSS % TYRA FCF ANAB FCF
FY 2025 $0 $234.6M — — -$95.3M $19.6M
FY 2024 $0 $91.3M — — -$70.4M -$135.7M
FY 2023 $0 $17.2M — — -$50.1M -$120.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TYRA // BETA —
ANAB // BETA —